Trial intelligence / Profile preview

IPM 003: Dapivirine Gel Safety and PK in Healthy Women

NCT00303576Phase 2Completed

Sponsor
International Partnership for Microbicides
Start
Oct 2005
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of dapivirine in human immunodeficiency virus infection (HIV), sponsored by International Partnership for Microbicides. Started Oct 2005; status: completed.

02

Drugs

dapivirine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00303576.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00303576.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call